CN Stock MarketDetailed Quotes

Suzhou Highfine Biotech (301393)

Watchlist
  • 50.37
  • +0.37+0.74%
Market Closed Dec 29 15:00 CST
5.44BMarket Cap39.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Highfine Biotech (301393) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Peptide synthesis reagent221.35M81.89%
通用型分子砌块29.71M10.99%
蛋白质试剂16.51M6.11%
Other products2.73M1.01%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Chemical raw materials and chemical products manufacturing451.87M100.00%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic sales191.13M70.71%
Export sales79.17M29.29%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.76%
Sample Name
Sample Code
 +2.17%
Sample Name
Sample Code
 +1.28%
4
BOSS ZHIPIN-W
02076
+0.57%
5
JD HEALTH
06618
+0.36%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +1.02%
Sample Name
Sample Code
 +0.89%
Sample Name
Sample Code
 +0.86%
4
Palo Alto Networks
PANW
+0.66%
5
Broadcom
AVGO
+0.55%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -